Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 14671189)

Published in J Clin Endocrinol Metab on December 01, 2003

Authors

Tasoula Tsilchorozidou1, John W Honour, Gerard S Conway

Author Affiliations

1: Departments of Endocrinology and Chemical Biochemistry, University College London Hospitals, London W1T 3AA, United Kingdom.

Articles citing this

Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril (2012) 1.45

Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes (2008) 1.08

Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med (2014) 0.89

Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency. J Endocrinol (2009) 0.84

The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83

Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab (2016) 0.81

Relative adrenal insufficiency in mice deficient in 5α-reductase 1. J Endocrinol (2014) 0.78

Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. J Endocrinol Invest (2009) 0.78

5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes. Endocrinology (2015) 0.77

Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome. Clin Med Insights Reprod Health (2016) 0.75

5α-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol (2017) 0.75

Corticotropic axis drive of overnight cortisol secretion is suppressed in adolescents and young adults with type 1 diabetes mellitus. Pediatr Diabetes (2013) 0.75

High Glucocorticoid Response to 24-h-Shift Stressors in Male but Not in Female Physicians. Front Endocrinol (Lausanne) (2017) 0.75

Articles by these authors

Premature ovarian failure. Hum Reprod Update (2005) 2.31

Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab (2007) 1.71

Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J Sex Res (2004) 1.44

A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf) (2007) 1.38

Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence. Clin Endocrinol (Oxf) (2012) 1.37

The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) (2004) 1.37

Normalization of the vagina by dilator treatment alone in Complete Androgen Insensitivity Syndrome and Mayer-Rokitansky-Kuster-Hauser Syndrome. Hum Reprod (2007) 1.24

Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia. Horm Behav (2006) 1.23

A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab (2004) 1.18

Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab (2005) 1.12

Cortical anatomy in human X monosomy. Neuroimage (2009) 1.12

Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin Endocrinol (Oxf) (2006) 1.11

Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. J Clin Endocrinol Metab (2009) 1.11

Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) (2009) 1.10

Holistic management of DSD. Best Pract Res Clin Endocrinol Metab (2010) 1.09

Influence of X chromosome and hormones on human brain development: a magnetic resonance imaging and proton magnetic resonance spectroscopy study of Turner syndrome. Biol Psychiatry (2005) 1.07

Premature ovarian failure. Horm Res (2007) 1.06

Sexual function in women with complete androgen insensitivity syndrome. Fertil Steril (2003) 1.04

Swyer syndrome. Curr Opin Endocrinol Diabetes Obes (2014) 1.03

Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab (2004) 1.02

Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab (2004) 1.01

Personality and congenital adrenal hyperplasia: possible effects of prenatal androgen exposure. Horm Behav (2008) 0.99

Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency. J Clin Endocrinol Metab (2010) 0.99

Management of ovarian disease in pregnancy. Best Pract Res Clin Endocrinol Metab (2011) 0.98

Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia. J Urol (2007) 0.97

Unusual results from immunoassays and the role of the clinical endocrinologist. Clin Endocrinol (Oxf) (2006) 0.97

Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome. Clin Endocrinol (Oxf) (2006) 0.96

Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. J Clin Endocrinol Metab (2005) 0.96

Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum Reprod (2010) 0.94

A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults. J Clin Endocrinol Metab (2013) 0.94

Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit's experience. Eur J Endocrinol (2006) 0.92

Revealing the diagnosis of androgen insensitivity syndrome in adulthood. BMJ (2005) 0.91

Perrault syndrome: further evidence for genetic heterogeneity. J Neurol (2011) 0.91

Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metab (2005) 0.90

A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf) (2007) 0.90

Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clin Endocrinol (Oxf) (2004) 0.88

A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as constitutional delay of growth and puberty with subsequent borderline oligospermia. J Clin Endocrinol Metab (2006) 0.88

Vitamin D status in patients with osteopenia or osteoporosis--an audit of an endocrine clinic. Int J Vitam Nutr Res (2006) 0.88

Evaluation of retained testes in adolescent girls and women with complete androgen insensitivity syndrome. Radiology (2013) 0.87

[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome. Eur J Endocrinol (2005) 0.87

Emotional and sexual wellness and quality of life in women with Rokitansky syndrome. Am J Obstet Gynecol (2011) 0.87

Androgenic influences on neural asymmetry: Handedness and language lateralization in individuals with congenital adrenal hyperplasia. Psychoneuroendocrinology (2004) 0.87

Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries. J Clin Endocrinol Metab (2008) 0.86

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. Int J Pediatr Endocrinol (2011) 0.86

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur J Endocrinol (2013) 0.84

Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab (2005) 0.83

XY females: revisiting the diagnosis. BJOG (2005) 0.83

Motor development in individuals with congenital adrenal hyperplasia: strength, targeting, and fine motor skill. Psychoneuroendocrinology (2008) 0.82

Analysis of LIN28A in early human ovary development and as a candidate gene for primary ovarian insufficiency. Mol Cell Endocrinol (2012) 0.82

Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice. Clin Endocrinol (Oxf) (2012) 0.81

Determinants of interleukin-6 and C-reactive protein vary in polycystic ovary syndrome, as do effects of short- and long-term metformin therapy. Horm Res (2009) 0.81

High risk pregnancies in hypopituitary women. Hum Reprod (2002) 0.80

Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic. Eur J Endocrinol (2011) 0.80

Management of hirsutism. BMJ (2009) 0.80

Giant cervical parathyroid adenoma mimicking a sternocleidomastoid mass and presenting as a brown tumor of the mandible. Clin Nucl Med (2007) 0.80

Adulthood in women with Turner syndrome. Horm Res (2003) 0.80

Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation. J Clin Endocrinol Metab (2002) 0.79

Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status. J Nutr Biochem (2005) 0.79

Adult care of pediatric conditions: lessons from Turner's syndrome. J Clin Endocrinol Metab (2009) 0.79

Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome. Clin Endocrinol (Oxf) (2006) 0.78

Serological screening for coeliac disease in adults with Turner's syndrome: prevalence and clinical significance of endomysium antibody positivity. Eur J Endocrinol (2009) 0.78

POLG mutations and age at menopause. Hum Reprod (2012) 0.78

A comparison of pain measures in newborn infants after cardiac surgery. Pain (2011) 0.77

Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS). Clin Endocrinol (Oxf) (2008) 0.77

Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters. Clin Endocrinol (Oxf) (2011) 0.76

Oestrogen deficiency and growth hormone treatment in childhood are not associated with hearing in adults with turner syndrome. Horm Res (2004) 0.76

Liver dysfunction in Turner syndrome and its relationship to exogenous oestrogen. Eur J Gastroenterol Hepatol (2013) 0.75

The effects of hormone replacement therapy on endothelial function in women with Turner's syndrome. Clin Endocrinol (Oxf) (2002) 0.75

Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin Endocrinol (Oxf) (2008) 0.75

Long-term health issues of women with XY karyotype. Maturitas (2010) 0.75